11:59 AM EST - Immunoprecise Antibodies Ltd. : Said its subsidiary, U-Protein Express BV, today announced the availability of its new recombinant SARS-CoV-2 proteins, and other proteins associated with COVID-19, for use by researchers globally in the design and discovery of novel therapeutics, vaccines and diagnostic test kits for coronavirus. Immunoprecise Antibodies Ltd.
shares V.IPA are trading down $0.05 at $1.89.
